ATE405255T1 - Behandlungs methode und lösung zur hemmung der trübung der hinteren kapsel - Google Patents

Behandlungs methode und lösung zur hemmung der trübung der hinteren kapsel

Info

Publication number
ATE405255T1
ATE405255T1 AT03797414T AT03797414T ATE405255T1 AT E405255 T1 ATE405255 T1 AT E405255T1 AT 03797414 T AT03797414 T AT 03797414T AT 03797414 T AT03797414 T AT 03797414T AT E405255 T1 ATE405255 T1 AT E405255T1
Authority
AT
Austria
Prior art keywords
agent
treatment solution
cells
treatment
epithelial cells
Prior art date
Application number
AT03797414T
Other languages
English (en)
Inventor
Jin Jun Zhang
Original Assignee
Jin Jun Zhang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jin Jun Zhang filed Critical Jin Jun Zhang
Application granted granted Critical
Publication of ATE405255T1 publication Critical patent/ATE405255T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Furan Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
AT03797414T 2002-09-17 2003-08-28 Behandlungs methode und lösung zur hemmung der trübung der hinteren kapsel ATE405255T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/244,878 US7985405B2 (en) 2002-09-17 2002-09-17 Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells

Publications (1)

Publication Number Publication Date
ATE405255T1 true ATE405255T1 (de) 2008-09-15

Family

ID=31991988

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03797414T ATE405255T1 (de) 2002-09-17 2003-08-28 Behandlungs methode und lösung zur hemmung der trübung der hinteren kapsel

Country Status (9)

Country Link
US (2) US7985405B2 (de)
EP (1) EP1542663B1 (de)
JP (1) JP4502811B2 (de)
CN (1) CN1700909B (de)
AT (1) ATE405255T1 (de)
AU (1) AU2003250495B2 (de)
CA (1) CA2499195C (de)
DE (1) DE60323107D1 (de)
WO (1) WO2004026288A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7985405B2 (en) 2002-09-17 2011-07-26 Jin Jun Zhang Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells
US7875270B2 (en) * 2002-09-17 2011-01-25 Abbott Medical Optics Inc. Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells
US20080039416A1 (en) * 2004-06-02 2008-02-14 Ho Steffan N Methods for Treating Disease by Modulating an Osmotic Stress Pathway
GB0419145D0 (en) * 2004-08-27 2004-09-29 Univ Dundee Treatment of posterior capsule opacification
WO2006045030A2 (en) * 2004-10-20 2006-04-27 Cell Ionix, Inc. Method and composition for eliminating ocular hypoxic acidosis
AU2006213997A1 (en) * 2005-02-19 2006-08-24 Lenticular Research Group Llc Apparatus and processes for preventing or delaying onset or progression of age-related cataract
US20120083772A1 (en) * 2010-09-30 2012-04-05 Curveright Llc Corneal treatment system and method
US9622911B2 (en) 2010-09-30 2017-04-18 Cxl Ophthalmics, Llc Ophthalmic treatment device, system, and method of use
CN102526103B (zh) * 2010-12-07 2013-11-13 西藏海思科药业集团股份有限公司 一种多种微量元素注射液药物组合物及其制备方法
US9555111B2 (en) 2012-03-29 2017-01-31 Cxl Ophthalmics, Llc Ocular cross-linking system and method for sealing corneal wounds
EP4420725A3 (de) 2012-03-29 2025-04-16 Epion Therapeutics, Inc. Augenbehandlungslösungen, abgabevorrichtungen und abgabeverstärkungsverfahren
WO2013149075A1 (en) 2012-03-29 2013-10-03 Cxl Ophthalmics, Llc Compositions and methods for treating or preventing diseases associated with oxidative stress
CN106986876B (zh) * 2017-03-20 2019-02-19 北京理工大学 一种靶向标记眼晶体上皮细胞的荧光探针、其制备及应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3241765A1 (de) 1982-11-11 1984-05-17 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin Stabile zubereitungen fuer injektionszwecke enthaltend hydrochlorothiazid
DE3906311A1 (de) 1989-02-28 1990-08-30 Adatomed Pharma & Med Behandlungsystem zur verhinderung von nachstarbildung nach einer kataraktoperation
WO1990009792A1 (en) * 1989-03-03 1990-09-07 The General Hospital Corporation Topical application of amiloride or analogues thereof for treatment of inflammation
DE69535673D1 (de) 1994-08-30 2008-02-07 Univ Dundee Mittel zur induktion von apoptosis und zur therapieanwendung
US6432934B1 (en) * 1998-08-06 2002-08-13 Advanced Vision Research Methods and compositions for topical treatment of eye surface inflammation and related dry eye disease
WO2000037072A1 (en) 1998-12-22 2000-06-29 Alcon Laboratories, Inc. Use of inhibitors of gag synthesis for the treatment of corneal haze
KR100784653B1 (ko) * 2000-01-26 2007-12-12 교린 세이야꾸 가부시키 가이샤 점안제
WO2003026744A1 (en) 2001-09-25 2003-04-03 Alcon, Inc. The use of epothilones and analogs in conjunction with ophthalmic surgery
US7985405B2 (en) 2002-09-17 2011-07-26 Jin Jun Zhang Treatment solution and method for preventing posterior capsular opacification by selectively inducing detachment and/or death of lens epithelial cells
SE0202924D0 (sv) 2002-10-03 2002-10-03 Pharmacia Groningen Bv Compositions for preventing posterior capsular opacification and the use therefor

Also Published As

Publication number Publication date
US7985405B2 (en) 2011-07-26
CA2499195A1 (en) 2004-04-01
HK1085130A1 (en) 2006-08-18
WO2004026288A1 (en) 2004-04-01
AU2003250495B2 (en) 2009-06-04
US20070129286A1 (en) 2007-06-07
EP1542663A1 (de) 2005-06-22
EP1542663B1 (de) 2008-08-20
CN1700909B (zh) 2011-05-18
US20040052823A1 (en) 2004-03-18
CA2499195C (en) 2011-05-24
CN1700909A (zh) 2005-11-23
JP4502811B2 (ja) 2010-07-14
AU2003250495A1 (en) 2004-04-08
US8114432B2 (en) 2012-02-14
JP2006507252A (ja) 2006-03-02
DE60323107D1 (de) 2008-10-02

Similar Documents

Publication Publication Date Title
ATE405255T1 (de) Behandlungs methode und lösung zur hemmung der trübung der hinteren kapsel
De Young et al. Effect of PDE5 inhibition combined with free oxygen radical scavenger therapy on erectile function in a diabetic animal model
BRPI0509332A (pt) implantes oculares biodegradáveis com caracterìsticas de liberação a longo prazo
BR0112361A (pt) Métodos para tratamento de condições oculares mediadas por inflamação
Zilla et al. High glutaraldehyde concentrations mitigate bioprosthetic root calcification in the sheep model
TW200719827A (en) Composition and method for in vitro preservation of corneal tissues
CA2590388A1 (en) A staining composition for staining an ophthalmic membrane
ATE288274T1 (de) Ophatlmologische zusammenssetzung
PE20060594A1 (es) Composicion farmaceutica que contiene un agonista de ppar
EP2269576A3 (de) Behandlungslösung und Verfahren zur Prävention von Trübungen der hinteren Kapsel durch selektive Induktion der Ablösung und/oder des Absterbens von Epithelzellen in der Linse
BR112012016128A2 (pt) agente terapêutico (y-39983) para disfunção endotelial da córnea
MX2007010295A (es) Composiciones oftalmologicas novedosas y metodo para su uso.
CA2453572A1 (en) The use of derivatives of 2,5-dihydroxybenxenesulphonic acids in the elaboration of a medicinal product to enhance the effect of other drugs used for the treatment of erectile disfunction
MX2023006724A (es) Gotas oftálmicas para tratar el adelgazamiento escleral y método de detección para el agente terapéutico de adelgazamiento escleral.
Gunay et al. Evaluation of autologous serum eyedrops for the treatment of experimentally induced corneal alcali burns
Hamdi Özkara et al. Changes of nitric oxide synthase-containing nerve fibers and parameters for oxidative stress after unilateral cavernous nerve resection or manuplation in rat penis
ATE491437T1 (de) Formulierungen mit alkylphosphocholinen unter verwendung von neuen negativen ladungsträgern
WO1994007499A1 (fr) Utilisation de derives de la flavine pour la realisation d'articles d'hygiene medico-chirurgicaux et les articles d'hygiene ainsi realises
AR069940A1 (es) Soluciones de irrigacion intraocular y metodos para tratar el edema de cornea
US20150344843A1 (en) Detergent treated biological tissue with low residual detergent and method of producing the same
AR016200A1 (es) El uso de una composicion que comprende uno o mas compuestos que contienen azufre para la fabricacion de un medicamento para aumentar la permeabilidad deltejido corneo humano, y un kit que incluye dicha composicion
RU2549476C1 (ru) Средство, обеспечивающее транспорт лекарственных средств через покровные ткани, и способ его применения
Shetty Evaluation of Echitamine, Ditamine and Echitenine for Anticataract Activity using in vitro cataract Model
RU2291675C2 (ru) Способ обработки трансплантатов для сердечно-сосудистой хирургии
RU2678966C1 (ru) Способ повышения биосовместимости перикардиальных биоматериалов для реконструктивной хирургии

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties